AN2 Therapeutics
ANTX
#8920
Rank
NZ$0.35 B
Marketcap
NZ$9.29
Share price
-2.68%
Change (1 day)
378.38%
Change (1 year)

EPS for AN2 Therapeutics (ANTX)

EPS in 2026 (TTM): NZ-$1.86

According to AN2 Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$1.96. In 2025 the company made an earnings per share (EPS) of NZ-$2.12 an increase over its 2024 EPS that were of NZ-$3.14.

EPS history for AN2 Therapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.86-12.45%
2025NZ-$2.12-32.56%
2024NZ-$3.14-39.01%
2023NZ-$5.15-40.02%
2022NZ-$8.59